Article Text
Statistics from Altmetric.com
During the first decade of the 20th century, long before John Simpson proposed that myasthenia gravis might be an autoimmune disorder, Oppenheim and Weigert identified tumours of the thymus in patients with myasthenia, leading to the theory that myasthenia might be an endocrine disorder. In 1911, Ernst Sauerbruch partially removed the thymus of a young myasthenic woman in the treatment of hyperthyroidism and was surprised to find that her myasthenia improved. This resulted in a variety of treatments directed against the thymus for myasthenia with varying results.
In 1939, Alfred Blalock removed a thymic tumour using the new technique of tracheal intubation and sternotomy, and in 1941, he performed the first trans-sternal thymectomy on a patient with myasthenia, but without a thymic tumour. By 1944, he had performed 20 such thymectomies with improvement in 13 patients. However, in 1947 he concluded, “I thought we had an answer to this problem of the relationship to the thymus and myasthenia, but such does not appear to be the case.”
Subsequent case series described varying techniques and outcomes, possibly accounted for by later evidence that successful thymectomy requires removal of microscopic islands of …
Footnotes
Competing interests None.
Provenance and peer review Commissioned; internally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Eculizumab versus rituximab in generalised myasthenia gravis
- Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan
- Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis
- Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials
- Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study
- Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis
- Rituximab in AChR subtype of myasthenia gravis: systematic review
- Update on myasthenia gravis
- Third distant recurrence of benign thymoma in a patient with myasthenia gravis
- Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan